Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia

Medicine & Life Sciences

• Case-Control Studies 4%
• Critical Care 5%
• Endotoxemia 76%
• Hydrogen Peroxide 5%
• In Vitro Techniques 2%
• Intensive Care Units 4%
• Interleukin-10 10%
• Interleukin-6 8%
• Lipopolysaccharides 4%
• Medical Schools 6%
• Multiple Organ Failure 6%
• Neutrophil Activation 79%
• Neutrophils 18%
• Organ Dysfunction Scores 23%
• Secretory Leukocyte Peptidase Inhibitor 100%
• Sepsis 51%
• Serum 28%
• Tumor Necrosis Factor-alpha 12%
• University Hospitals 4%
• Wounds and Injuries 5%